Dimensional Fund Advisors LP Applied Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $1,785 - $6,201	-2,349 Reduced 5.98%	36,961 $35,000
Q1 2022 May 13, 2022	SELL	$1.48 - $6.22 $49,750 - $209,085	-33,615 Reduced 46.1%	39,310 $83,000
Q4 2021 Feb 09, 2022	BUY	$8.77 - $18.29 $199,438 - $415,932	22,741 Added 45.32%	72,925 $653,000
Q3 2021 Nov 12, 2021	BUY	$13.54 - $22.06 $467,414 - $761,533	34,521 Added 220.4%	50,184 $832,000
Q2 2021 Aug 12, 2021	BUY	$14.05 - $25.04 $220,065 - $392,201	15,663 New	15,663 $325,000

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $60M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.